References
- Maxmen, A., 2021. One million coronavirus sequences: popular genome
site hits mega milestone. Nature 593, 21.
- Mavian, C., Marini, S., Prosperi, M., Salemi, M., 2020. Authors’ Reply
to: Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a
Maximum Likelihood Tree. Comment on ”A Snapshot of SARS-CoV-2 Genome
Availability up to April 2020 and its Implications: Data Analysis”.
JMIR Public Health Surveill 6, e24661.
- Tegally, H., Moir, M., Everatt, J., Giovanetti, M., Scheepers, C.,
Wilkinson, E., Subramoney, K., Makatini, Z., Moyo, S., Amoako, D.G.,
Baxter, C., Althaus, C.L., Anyaneji, U.J., Kekana, D., Viana, R.,
Giandhari, J., Lessells, R.J., Maponga, T., Maruapula, D., Choga, W.,
Matshaba, M., Mbulawa, M.B., Msomi, N., consortium, N.-S., Naidoo, Y.,
Pillay, S., Sanko, T.J., San, J.E., Scott, L., Singh, L., Magini,
N.A., Smith-Lawrence, P., Stevens, W., Dor, G., Tshiabuila, D.,
Wolter, N., Preiser, W., Treurnicht, F.K., Venter, M., Chiloane, G.,
McIntyre, C., O’Toole, A., Ruis, C., Peacock, T.P., Roemer, C.,
Kosakovsky Pond, S.L., Williamson, C., Pybus, O.G., Bhiman, J.N.,
Glass, A., Martin, D.P., Jackson, B., Rambaut, A., Laguda-Akingba, O.,
Gaseitsiwe, S., von Gottberg, A., de Oliveira, T., 2022. Emergence of
SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med 28,
1785-1790.
- Velazquez-Salinas, L., Zarate, S., Eberl, S., Gladue, D.P., Novella,
I., Borca, M.V., 2020. Positive Selection of ORF1ab, ORF3a, and ORF8
Genes Drives the Early Evolutionary Trends of SARS-CoV-2 During the
2020 COVID-19 Pandemic. Frontiers in Microbiology 11.
- Martin, D.P., Weaver, S., Tegally, H., San, J.E., Shank, S.D.,
Wilkinson, E., Lucaci, A.G., Giandhari, J., Naidoo, S., Pillay, Y.,
Singh, L., Lessells, R.J., Ngs, S.A., UK, C.-G., Gupta, R.K.,
Wertheim, J.O., Nekturenko, A., Murrell, B., Harkins, G.W., Lemey, P.,
MacLean, O.A., Robertson, D.L., de Oliveira, T., Kosakovsky Pond,
S.L., 2021. The emergence and ongoing convergent evolution of the
SARS-CoV-2 N501Y lineages. Cell 184, 5189-5200 e5187.
- Velazquez-Salinas, L., 2022. The complex evolutionary dynamics of
SARS-CoV-2, a big challenge to control the pandemic of COVID-19. J Med
Virol 94, 5082-5085.
- O’Toole, A., Pybus, O.G., Abram, M.E., Kelly, E.J., Rambaut, A., 2022.
Pango lineage designation and assignment using SARS-CoV-2 spike gene
nucleotide sequences. BMC Genomics 23, 121.
- Weaver, S., Shank, S.D., Spielman, S.J., Li, M., Muse, S.V.,
Kosakovsky Pond, S.L., 2018. Datamonkey 2.0: A Modern Web Application
for Characterizing Selective and Other Evolutionary Processes. Mol
Biol Evol 35, 773-777.
- Zhang, Y., Zhang, T., Fang, Y., Liu, J., Ye, Q., Ding, L., 2022.
SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity
and infectivity as well as host glycolysis. Signal Transduct Target
Ther 7, 76.
- Liu, L., Iketani, S., Guo, Y., Chan, J.F., Wang, M., Liu, L., Luo, Y.,
Chu, H., Huang, Y., Nair, M.S., Yu, J., Chik, K.K., Yuen, T.T., Yoon,
C., To, K.K., Chen, H., Yin, M.T., Sobieszczyk, M.E., Huang, Y., Wang,
H.H., Sheng, Z., Yuen, K.Y., Ho, D.D., 2022. Striking antibody evasion
manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676-681.
- Maaroufi, H., 2022. The N764K and N856K mutations in SARS-CoV-2
Omicron S protein generate potential cleavage sites for SKI-1/S1P
protease. bioRxiv, 2022.2001.2021.477298.
- Oulas, A., Zanti, M., Tomazou, M., Zachariou, M., Minadakis, G.,
Bourdakou, M.M., Pavlidis, P., Spyrou, G.M., 2021. Generalized linear
models provide a measure of virulence for specific mutations in
SARS-CoV-2 strains. PLoS One 16, e0238665.
- Benvenuto, D., Angeletti, S., Giovanetti, M., Bianchi, M., Pascarella,
S., Cauda, R., Ciccozzi, M., Cassone, A., 2020. Evolutionary analysis
of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could
affect viral autophagy. J Infect 81, e24-e27.
- Wertheim, J.O., Murrell, B., Smith, M.D., Kosakovsky Pond, S.L.,
Scheffler, K., 2015. RELAX: detecting relaxed selection in a
phylogenetic framework. Mol Biol Evol 32, 820-832.
- Hachmann, N.P., Miller, J., Collier, A.Y., Barouch, D.H., 2022.
Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6. N Engl
J Med 387, 1904-1906.
- Wang, R., Chen, J., Wei, G.W., 2021. Mechanisms of SARS-CoV-2
Evolution Revealing Vaccine-Resistant Mutations in Europe and America.
J Phys Chem Lett 12, 11850-11857.
- Smith, M.D., Wertheim, J.O., Weaver, S., Murrell, B., Scheffler, K.,
Kosakovsky Pond, S.L., 2015. Less is more: an adaptive branch-site
random effects model for efficient detection of episodic diversifying
selection. Mol Biol Evol 32, 1342-1353.
- Murrell, B., Weaver, S., Smith, M.D., Wertheim, J.O., Murrell, S.,
Aylward, A., Eren, K., Pollner, T., Martin, D.P., Smith, D.M.,
Scheffler, K., Kosakovsky Pond, S.L., 2015. Gene-wide identification
of episodic selection. Mol Biol Evol 32, 1365-1371.
- Murrell, B., Wertheim, J.O., Moola, S., Weighill, T., Scheffler, K.,
Kosakovsky Pond, S.L., 2012. Detecting individual sites subject to
episodic diversifying selection. PLoS Genet 8, e1002764.
- Khare, S., Gurry, C., Freitas, L., Schultz, M.B., Bach, G., Diallo,
A., Akite, N., Ho, J., Lee, R.T., Yeo, W., Curation Team, G.C.,
Maurer-Stroh, S., 2021. GISAID’s Role in Pandemic Response. China CDC
Wkly 3, 1049-1051.
- Colson, P., Gautret, P., Delerce, J., Chaudet, H., Pontarotti, P.,
Forterre, P., Tola, R., Bedotto, M., Delorme, L., Bader, W.,
Levasseur, A., Lagier, J.C., Million, M., Yahi, N., Fantini, J., La
Scola, B., Fournier, P.E., Raoult, D., 2022. The emergence, spread and
vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA
virus epidemics and obeys the Mistigri rule. J Med Virol.
- Hachim, A., Kavian, N., Cohen, C.A., Chin, A.W.H., Chu, D.K.W., Mok,
C.K.P., Tsang, O.T.Y., Yeung, Y.C., Perera, R., Poon, L.L.M., Peiris,
J.S.M., Valkenburg, S.A., 2020. ORF8 and ORF3b antibodies are accurate
serological markers of early and late SARS-CoV-2 infection. Nat
Immunol 21, 1293-1301.
- Moody, R., Wilson, K.L., Boer, J.C., Holien, J.K., Flanagan, K.L.,
Jaworowski, A., Plebanski, M., 2021. Predicted B Cell Epitopes
Highlight the Potential for COVID-19 to Drive Self-Reactive Immunity.
Front Bioinform 1, 709533.
- Silvas, J.A., Vasquez, D.M., Park, J.G., Chiem, K., Allue-Guardia, A.,
Garcia-Vilanova, A., Platt, R.N., Miorin, L., Kehrer, T., Cupic, A.,
Gonzalez-Reiche, A.S., Bakel, H.V., Garcia-Sastre, A., Anderson, T.,
Torrelles, J.B., Ye, C., Martinez-Sobrido, L., 2021. Contribution of
SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2
Transgenic Mice. J Virol 95, e0040221.
- Li, J.Y., Liao, C.H., Wang, Q., Tan, Y.J., Luo, R., Qiu, Y., Ge, X.Y.,
2020. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit
type I interferon signaling pathway. Virus Res 286, 198074.
- Geng, H., Subramanian, S., Wu, L., Bu, H.F., Wang, X., Du, C., De
Plaen, I.G., Tan, X.D., 2021. SARS-CoV-2 ORF8 Forms Intracellular
Aggregates and Inhibits IFNgamma-Induced Antiviral Gene Expression in
Human Lung Epithelial Cells. Front Immunol 12, 679482.
- Chou, J.M., Tsai, J.L., Hung, J.N., Chen, I.H., Chen, S.T., Tsai,
M.H., 2022. The ORF8 Protein of SARS-CoV-2 Modulates the Spike Protein
and Its Implications in Viral Transmission. Front Microbiol 13,
883597.
- Kosakovsky Pond, S.L., Frost, S.D., 2005. Not so different after all:
a comparison of methods for detecting amino acid sites under
selection. Mol Biol Evol 22, 1208-1222.